You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0802 Endothelin1 receptor-antagonism (bosentan) reduces the progression of microvascular damage as assessed by nailfold capillaroscopy in systemic sclerosis patients: A 2 year survey

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Scleroderma, myositis and related syndromes – clinical aspects and treatment
AB0802 Endothelin1 receptor-antagonism (bosentan) reduces the progression of microvascular damage as assessed by nailfold capillaroscopy in systemic sclerosis patients: A 2 year survey

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Cutolo M, Vremis L, Zampogna G, et al
AB0802 Endothelin1 receptor-antagonism (bosentan) reduces the progression of microvascular damage as assessed by nailfold capillaroscopy in systemic sclerosis patients: A 2 year survey
Annals of the Rheumatic Diseases 2013;71:684.